FDA Shake-up: Unprecedented Staff Cuts Spark Uncertainty in Biotech’s Future
A significant restructuring is occurring within the U.S. FDA and HHS, affecting thousands of positions and raising concerns about the future of innovative medicine in America. Peter Marks, former director…